Quick Answer
BIO-PATH HOLDINGS, INC. reported Diluted EPS of $4.12 per share (loss) for fiscal year 2024.
BIO-PATH HOLDINGS, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$4.12 | +87.7% |
| 2023 | -$33.63 | +11.8% |
| 2022 | -$38.12 | -2359.4% |
| 2021 | -$1.55 | +45.2% |
| 2020 | -$2.83 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.11 | +84.3% | +80.0% |
| June 30, 2025 | -$0.55 | +52.6% | -37.5% |
| March 31, 2025 | -$0.40 | +91.8% | +42.9% |
| September 30, 2024 | -$0.70 | +89.0% | +39.7% |
| June 30, 2024 | -$1.16 | +89.1% | +76.2% |
| March 31, 2024 | -$4.88 | +63.2% | +23.3% |
| September 30, 2023 | -$6.36 | -1198.0% | +40.2% |
| June 30, 2023 | -$10.64 | -2433.3% | +19.7% |
- BIO-PATH HOLDINGS, INC. showed an increase of +87.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, BIO-PATH HOLDINGS, INC.’s diluted eps has declined by 45.6% (from $2.83 per share (loss) to $4.12 per share (loss)).
- The most recent figure is from BIO-PATH HOLDINGS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: